Clovis Oncology Inc (NASDAQ:CLVS)

50.17
Delayed Data
As of Apr 20
 -1.15 / -2.24%
Today’s Change
45.42
Today|||52-Week Range
99.45
-26.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues13.6M0.0078.0K55.5M
 
 
 
 
Cost of Goods Sold0.000.0070.0K9.2M
 
 
 
Depreciation And Amortization3.9M761.0K1.1M2.5M
 
 
 
 
 
 
Operating ExpensesGross Income9.8M-761.0K-1.1M43.8M
 
 
 
 
 
General Expenses158.7M299.0M290.7M281.4M
 
 
 
 
 
Research And Development137.7M269.3M251.1M142.5M
 
 
 
 
 
Total Operating Expenses162.6M299.8M291.9M293.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-148.9M-299.8M-291.9M-237.6M
 
 
 
 
 
Extraordinary Credit--24.6M24.9M0.00
 
 
 
Extraordinary Charge-9.5M-101.6M-105.8M-105.5M
 
 
 
 
 
Interest Expense On Debt2.6M8.4M8.5M10.4M
 
 
 
 
 
Other Expenses3.3M3.2M53.0K3.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-157.7M-381.9M-381.2M-350.0M
 
 
 
 
 
Income Taxes-2.3M-29.1M-32.0M-3.6M
 
 
 
 
 
Net Income-160.0M-352.9M-349.1M-346.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.9M36.0M38.5M47.0M
 
 
 
 
 
Shares To Calculate EPS Diluted33.9M36.0M38.5M47.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.72-$9.79-$9.07-$7.36
 
 
 
 
 
EPS Diluted-$4.72-$9.79-$9.07-$7.36